Evidence for A Macromolecular Complex in Poor Prognostic CLL That Contains CD38, CD49d, CD44, MMP-9 and ZAP-70

Andrea Buggins, Ana Levi, Satyen Gohill, Keith Fishlock, Piers Patten, Deborah Yallop, Ghulam Mufti, Stephen Devereux

Research output: Contribution to journalMeeting abstract

Abstract

The outcome for patients with Chronic Lymphocytic Leukemia (CLL) is highly variable and correlates with clinical parameters such as disease stage, as well as various biological markers that reflect the genomic, phenotypic and functional properties of the tumor and its microenvironment. CD38, Cd49d and ZAP-70 are three such markers that are associated with a poor clinical outcome and which have previously been shown to play a role in migration. Progressive disease is invariably associated with tissue invasion. In the present study we investigated the possibility that the markers CD38, CD49d and ZAP-70 might be physically associated as well as functionally linked. Using 4-color flow cytometry we measured the level of expression of CD38 and CD49d by CD19+/CD5+ CLL cells in patients with CLL presenting to our routine diagnostic laboratory. A correlation was observed between both the percentage positivity and mean fluorescent intensity of CD38 and CD49d expression (r2=0.42, p=
Original languageEnglish
Article number2334
JournalBlood
Publication statusPublished - 2009
EventAmerican Society of Hematology - New Orleans
Duration: 4 Dec 20098 Dec 2009

Fingerprint

Dive into the research topics of 'Evidence for A Macromolecular Complex in Poor Prognostic CLL That Contains CD38, CD49d, CD44, MMP-9 and ZAP-70'. Together they form a unique fingerprint.

Cite this